{"id":393966,"date":"2026-02-11T17:36:50","date_gmt":"2026-02-11T17:36:50","guid":{"rendered":"https:\/\/xtrategicalpharma.com\/regulamento-ehds-no-setor-farmaceutico\/"},"modified":"2026-02-23T08:51:19","modified_gmt":"2026-02-23T08:51:19","slug":"regulamento-ehds-no-setor-farmaceutico","status":"publish","type":"post","link":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/","title":{"rendered":"EHDS Regulation in the Pharmaceutical Sector"},"content":{"rendered":"<h1 data-path-to-node=\"4\">The New EHDS Regulation in the Pharmaceutical Sector: Challenges and Opportunities<\/h1>\n<p data-path-to-node=\"5\">The <b data-path-to-node=\"5\" data-index-in-node=\"4\">EHDS Regulation in the Pharmaceutical Sector<\/b> represents a historic milestone in European legislation, following its publication in March 2025 (Regulation EU 2025\/327). Rather than being just a technical framework, the European Health Data Space is an ambitious ecosystem designed to promote interoperability. By ensuring security, it allows innovation to occur ethically and efficiently across all EU Member States through the primary and secondary use of health data.<\/p>\n<p data-path-to-node=\"5\">Regarding the <b data-path-to-node=\"6\" data-index-in-node=\"14\">primary use of data<\/b>, the regulation establishes a mechanism that allows citizens free access to their records via the MyHealth@EU digital infrastructure. This information is obtained directly from health services. Consequently, patients can share data with professionals, restrict access, or request rectifications.<\/p>\n<p data-path-to-node=\"5\">Furthermore, the <b data-path-to-node=\"7\" data-index-in-node=\"17\">secondary use of health data<\/b> focuses on the reuse of information for research, innovation, and public health. This pillar is essential for health policymaking and the advancement of personalised medicine.<\/p>\n<h3 data-path-to-node=\"7\">The Strategic Value of This New Legislation<\/h3>\n<p>For industry decision-makers, understanding the direct impact of this regulation is vital for competitive survival. This new legal framework facilitates access to high-quality health data for secondary purposes. In practice, scientific research and the development of new therapies will be significantly accelerated by <b data-path-to-node=\"9\" data-index-in-node=\"319\">Real World Evidence (RWE)<\/b> shared transparently.<\/p>\n<p data-path-to-node=\"10\">To achieve these goals, Europe focuses on four fundamental pillars:<\/p>\n<ul data-path-to-node=\"11\">\n<li>\n<p data-path-to-node=\"11,0,0\"><b data-path-to-node=\"11,0,0\" data-index-in-node=\"0\">Cross-border Interoperability:<\/b> Systems that communicate with each other, eliminating information silos.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"11,1,0\"><b data-path-to-node=\"11,1,0\" data-index-in-node=\"0\">Patient Empowerment:<\/b> Citizens gain direct access and total management of clinical records.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"11,2,0\"><b data-path-to-node=\"11,2,0\" data-index-in-node=\"0\">Enhanced Security:<\/b> Rigorous standards ensure absolute data privacy and protection.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"11,3,0\"><b data-path-to-node=\"11,3,0\" data-index-in-node=\"0\">Faster Innovation:<\/b> Improved access to information for biopharmaceutical companies and research centers.<\/p>\n<\/li>\n<\/ul>\n<h3 data-path-to-node=\"11\">Regulatory Compliance and Evidence Generation with Xtrategical Pharma Consulting<\/h3>\n<p data-path-to-node=\"12\">Implementing these rules requires a vision that combines up-to-date regulatory knowledge with market insight. At <b data-path-to-node=\"13\" data-index-in-node=\"113\">Xtrategical Pharma Consulting<\/b>, we specialize in transforming complex regulatory changes into real competitive advantages. In addition, we accelerate evidence generation to support technical-scientific strategies and informed health decisions.<\/p>\n<p data-path-to-node=\"13\">You can consult the technical details directly on the <a href=\"https:\/\/health.ec.europa.eu\/ehealth-digital-health-and-care\/european-health-data-space-regulation-ehds_pt\" target=\"_blank\" rel=\"noopener\"><b data-path-to-node=\"14\" data-index-in-node=\"54\">European Commission<\/b><\/a> portal. Ultimately, the future of healthcare in Europe is digital. With the right strategic support, your company will not only meet the new requirements but lead the digital transformation in the global pharmaceutical sector.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The New EHDS Regulation in the Pharmaceutical Sector: Challenges and Opportunities The EHDS Regulation in the Pharmaceutical Sector represents a historic milestone in European legislation, following its publication in March 2025 (Regulation EU 2025\/327). Rather than being just a technical framework, the European Health Data Space is an ambitious ecosystem designed to promote interoperability. By [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"<p data-path-to-node=\"4\">O <b data-path-to-node=\"4\" data-index-in-node=\"2\">Espa\u00e7o Europeu de Dados de Sa\u00fade (EHDS)<\/b> n\u00e3o \u00e9 apenas uma nova regulamenta\u00e7\u00e3o; \u00e9 o pilar que ir\u00e1 redefinir a forma como a sa\u00fade \u00e9 gerida na Europa. Com a sua implementa\u00e7\u00e3o, a Uni\u00e3o Europeia cria um ecossistema \u00fanico que desbloqueia o potencial dos dados de sa\u00fade para a presta\u00e7\u00e3o de cuidados, investiga\u00e7\u00e3o e inova\u00e7\u00e3o.<\/p><h3 data-path-to-node=\"5\">Por que deve a Ind\u00fastria estar atenta?<\/h3><p data-path-to-node=\"6\">A cria\u00e7\u00e3o deste espa\u00e7o comum traz oportunidades cr\u00edticas, mas tamb\u00e9m desafios de conformidade que exigem uma adapta\u00e7\u00e3o estrat\u00e9gica imediata:<\/p><ul data-path-to-node=\"7\"><li><p data-path-to-node=\"7,0,0\"><b data-path-to-node=\"7,0,0\" data-index-in-node=\"0\">Acesso a Dados para Investiga\u00e7\u00e3o (Uso Secund\u00e1rio):<\/b> O EHDS facilitar\u00e1 o acesso a dados de sa\u00fade de alta qualidade em toda a UE de forma segura e an\u00f3nima. Isto permitir\u00e1 acelerar o desenvolvimento de novos medicamentos e dispositivos m\u00e9dicos atrav\u00e9s de evid\u00eancias de mundo real (<b data-path-to-node=\"7,0,0\" data-index-in-node=\"277\">Real World Evidence<\/b>).<\/p><\/li><li><p data-path-to-node=\"7,1,0\"><b data-path-to-node=\"7,1,0\" data-index-in-node=\"0\">Interoperabilidade e Standardiza\u00e7\u00e3o:<\/b> A obrigatoriedade de formatos comuns de dados de sa\u00fade exigir\u00e1 que as empresas revejam os seus sistemas e processos de recolha de informa\u00e7\u00e3o.<\/p><\/li><li><p data-path-to-node=\"7,2,0\"><b data-path-to-node=\"7,2,0\" data-index-in-node=\"0\">Capacita\u00e7\u00e3o do Doente:<\/b> Com o maior controlo dos cidad\u00e3os sobre os seus dados, as estrat\u00e9gias de <i data-path-to-node=\"7,2,0\" data-index-in-node=\"96\">patient engagement<\/i> tornam-se centrais para o sucesso cl\u00ednico e comercial.<\/p><\/li><\/ul><h3 data-path-to-node=\"8\">Como a Xtrategical Pharma Consulting pode ajudar?<\/h3><p data-path-to-node=\"9\">Na <b data-path-to-node=\"9\" data-index-in-node=\"3\">Xtrategical<\/b>, antecipamos o impacto destas mudan\u00e7as legislativas no ciclo de vida dos produtos. Ajudamos os nossos clientes a navegar neste novo quadro regulamentar, garantindo que a transi\u00e7\u00e3o para a era dos dados de sa\u00fade seja uma alavanca de crescimento e n\u00e3o um obst\u00e1culo.<\/p><blockquote data-path-to-node=\"10\"><p data-path-to-node=\"10,0\"><b data-path-to-node=\"10,0\" data-index-in-node=\"0\">\"O EHDS ser\u00e1 o motor da medicina personalizada na Europa. Estar preparado hoje \u00e9 garantir a competitividade de amanh\u00e3.\"<\/b><\/p><\/blockquote>","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-393966","post","type-post","status-publish","format-standard","hentry","category-sem-categoria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EHDS Regulation in the Pharmaceutical Sector | Xtrategical<\/title>\n<meta name=\"description\" content=\"Saiba como o Regulamento EHDS impacta a Ind\u00fastria Farmac\u00eautica. Explore as novas regras de dados de sa\u00fade e inova\u00e7\u00e3o na Europa.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EHDS Regulation in the Pharmaceutical Sector | Xtrategical\" \/>\n<meta property=\"og:description\" content=\"Saiba como o Regulamento EHDS impacta a Ind\u00fastria Farmac\u00eautica. Explore as novas regras de dados de sa\u00fade e inova\u00e7\u00e3o na Europa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/\" \/>\n<meta property=\"og:site_name\" content=\"xtrategicalpharma.com\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-11T17:36:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T08:51:19+00:00\" \/>\n<meta name=\"author\" content=\"xtrategical\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"xtrategical\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/\"},\"author\":{\"name\":\"xtrategical\",\"@id\":\"https:\/\/xtrategicalpharma.com\/#\/schema\/person\/0cc3563c875c706a308b63df3f7ba35e\"},\"headline\":\"EHDS Regulation in the Pharmaceutical Sector\",\"datePublished\":\"2026-02-11T17:36:50+00:00\",\"dateModified\":\"2026-02-23T08:51:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/\"},\"wordCount\":368,\"commentCount\":0,\"articleSection\":[\"Sem categoria\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/\",\"url\":\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/\",\"name\":\"EHDS Regulation in the Pharmaceutical Sector | Xtrategical\",\"isPartOf\":{\"@id\":\"https:\/\/xtrategicalpharma.com\/#website\"},\"datePublished\":\"2026-02-11T17:36:50+00:00\",\"dateModified\":\"2026-02-23T08:51:19+00:00\",\"author\":{\"@id\":\"https:\/\/xtrategicalpharma.com\/#\/schema\/person\/0cc3563c875c706a308b63df3f7ba35e\"},\"description\":\"Saiba como o Regulamento EHDS impacta a Ind\u00fastria Farmac\u00eautica. Explore as novas regras de dados de sa\u00fade e inova\u00e7\u00e3o na Europa.\",\"breadcrumb\":{\"@id\":\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/xtrategicalpharma.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EHDS Regulation in the Pharmaceutical Sector\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/xtrategicalpharma.com\/#website\",\"url\":\"https:\/\/xtrategicalpharma.com\/\",\"name\":\"xtrategicalpharma.com\",\"description\":\"Consultoria Estrat\u00e9gica de Excel\u00eancia\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/xtrategicalpharma.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/xtrategicalpharma.com\/#\/schema\/person\/0cc3563c875c706a308b63df3f7ba35e\",\"name\":\"xtrategical\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/xtrategicalpharma.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c25801a4ca8a6fd0d82369fbf4217cf4f1acb1acdf7fc8a55c994814477ce4ee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c25801a4ca8a6fd0d82369fbf4217cf4f1acb1acdf7fc8a55c994814477ce4ee?s=96&d=mm&r=g\",\"caption\":\"xtrategical\"},\"url\":\"https:\/\/xtrategicalpharma.com\/en\/author\/xtrategical\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EHDS Regulation in the Pharmaceutical Sector | Xtrategical","description":"Saiba como o Regulamento EHDS impacta a Ind\u00fastria Farmac\u00eautica. Explore as novas regras de dados de sa\u00fade e inova\u00e7\u00e3o na Europa.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/","og_locale":"en_US","og_type":"article","og_title":"EHDS Regulation in the Pharmaceutical Sector | Xtrategical","og_description":"Saiba como o Regulamento EHDS impacta a Ind\u00fastria Farmac\u00eautica. Explore as novas regras de dados de sa\u00fade e inova\u00e7\u00e3o na Europa.","og_url":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/","og_site_name":"xtrategicalpharma.com","article_published_time":"2026-02-11T17:36:50+00:00","article_modified_time":"2026-02-23T08:51:19+00:00","author":"xtrategical","twitter_card":"summary_large_image","twitter_misc":{"Written by":"xtrategical","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/#article","isPartOf":{"@id":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/"},"author":{"name":"xtrategical","@id":"https:\/\/xtrategicalpharma.com\/#\/schema\/person\/0cc3563c875c706a308b63df3f7ba35e"},"headline":"EHDS Regulation in the Pharmaceutical Sector","datePublished":"2026-02-11T17:36:50+00:00","dateModified":"2026-02-23T08:51:19+00:00","mainEntityOfPage":{"@id":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/"},"wordCount":368,"commentCount":0,"articleSection":["Sem categoria"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/","url":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/","name":"EHDS Regulation in the Pharmaceutical Sector | Xtrategical","isPartOf":{"@id":"https:\/\/xtrategicalpharma.com\/#website"},"datePublished":"2026-02-11T17:36:50+00:00","dateModified":"2026-02-23T08:51:19+00:00","author":{"@id":"https:\/\/xtrategicalpharma.com\/#\/schema\/person\/0cc3563c875c706a308b63df3f7ba35e"},"description":"Saiba como o Regulamento EHDS impacta a Ind\u00fastria Farmac\u00eautica. Explore as novas regras de dados de sa\u00fade e inova\u00e7\u00e3o na Europa.","breadcrumb":{"@id":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/xtrategicalpharma.com\/en\/regulamento-ehds-no-setor-farmaceutico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/xtrategicalpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"EHDS Regulation in the Pharmaceutical Sector"}]},{"@type":"WebSite","@id":"https:\/\/xtrategicalpharma.com\/#website","url":"https:\/\/xtrategicalpharma.com\/","name":"xtrategicalpharma.com","description":"Consultoria Estrat\u00e9gica de Excel\u00eancia","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xtrategicalpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/xtrategicalpharma.com\/#\/schema\/person\/0cc3563c875c706a308b63df3f7ba35e","name":"xtrategical","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xtrategicalpharma.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c25801a4ca8a6fd0d82369fbf4217cf4f1acb1acdf7fc8a55c994814477ce4ee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c25801a4ca8a6fd0d82369fbf4217cf4f1acb1acdf7fc8a55c994814477ce4ee?s=96&d=mm&r=g","caption":"xtrategical"},"url":"https:\/\/xtrategicalpharma.com\/en\/author\/xtrategical\/"}]}},"_links":{"self":[{"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/posts\/393966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/comments?post=393966"}],"version-history":[{"count":3,"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/posts\/393966\/revisions"}],"predecessor-version":[{"id":393969,"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/posts\/393966\/revisions\/393969"}],"wp:attachment":[{"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/media?parent=393966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/categories?post=393966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xtrategicalpharma.com\/en\/wp-json\/wp\/v2\/tags?post=393966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}